1632 related articles for article (PubMed ID: 15125842)
1. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
Stitt TN; Drujan D; Clarke BA; Panaro F; Timofeyva Y; Kline WO; Gonzalez M; Yancopoulos GD; Glass DJ
Mol Cell; 2004 May; 14(3):395-403. PubMed ID: 15125842
[TBL] [Abstract][Full Text] [Related]
2. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
Tong JF; Yan X; Zhu MJ; Du M
J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes.
Wang DT; Yin Y; Yang YJ; Lv PJ; Shi Y; Lu L; Wei LB
Int Immunopharmacol; 2014 Apr; 19(2):206-13. PubMed ID: 24534773
[TBL] [Abstract][Full Text] [Related]
5. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
Sandri M; Sandri C; Gilbert A; Skurk C; Calabria E; Picard A; Walsh K; Schiaffino S; Lecker SH; Goldberg AL
Cell; 2004 Apr; 117(3):399-412. PubMed ID: 15109499
[TBL] [Abstract][Full Text] [Related]
6. Iron-induced skeletal muscle atrophy involves an Akt-forkhead box O3-E3 ubiquitin ligase-dependent pathway.
Ikeda Y; Imao M; Satoh A; Watanabe H; Hamano H; Horinouchi Y; Izawa-Ishizawa Y; Kihira Y; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
J Trace Elem Med Biol; 2016 May; 35():66-76. PubMed ID: 27049128
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth.
Lee D; Goldberg AL
J Biol Chem; 2013 Oct; 288(42):30515-30526. PubMed ID: 24003218
[TBL] [Abstract][Full Text] [Related]
8. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
9. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.
Latres E; Amini AR; Amini AA; Griffiths J; Martin FJ; Wei Y; Lin HC; Yancopoulos GD; Glass DJ
J Biol Chem; 2005 Jan; 280(4):2737-44. PubMed ID: 15550386
[TBL] [Abstract][Full Text] [Related]
11. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
Tang H; Inoki K; Lee M; Wright E; Khuong A; Khuong A; Sugiarto S; Garner M; Paik J; DePinho RA; Goldman D; Guan KL; Shrager JB
Sci Signal; 2014 Feb; 7(314):ra18. PubMed ID: 24570486
[TBL] [Abstract][Full Text] [Related]
12. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy.
Glass DJ
Nat Cell Biol; 2003 Feb; 5(2):87-90. PubMed ID: 12563267
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
14. Excessive glucocorticoid-induced muscle MuRF1 overexpression is independent of Akt/FoXO1 pathway.
Wang XJ; Xiao JJ; Liu L; Jiao HC; Lin H
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046370
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
16. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
18. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression.
Yoshida T; Semprun-Prieto L; Sukhanov S; Delafontaine P
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1565-70. PubMed ID: 20228261
[TBL] [Abstract][Full Text] [Related]
20. Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor.
Zhao W; Qin W; Pan J; Wu Y; Bauman WA; Cardozo C
Biochem Biophys Res Commun; 2009 Jan; 378(3):668-72. PubMed ID: 19059383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
